Erratum
Multimed Inc., Milton, ON L9T 2R2, Canada
Curr. Oncol. 2009, 16(5), 120; https://doi.org/10.3390/curroncol16050001
Submission received: 2 June 2009
/
Revised: 10 July 2009
/
Accepted: 4 August 2009
/
Published: 1 September 2009
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
Please be advised that there is an error in Table I of “The Role of HER2-targeted Therapies in Women with HER2-Overexpressing Metastatic Breast Cancer” by Dent et al. which appeared in Current Oncology Volume 16, Number 4 on page 236 in print, and page 26 online [...]
Share and Cite
MDPI and ACS Style
Current Oncology Editorial Office. Erratum. Curr. Oncol. 2009, 16, 120. https://doi.org/10.3390/curroncol16050001
AMA Style
Current Oncology Editorial Office. Erratum. Current Oncology. 2009; 16(5):120. https://doi.org/10.3390/curroncol16050001
Chicago/Turabian StyleCurrent Oncology Editorial Office. 2009. "Erratum" Current Oncology 16, no. 5: 120. https://doi.org/10.3390/curroncol16050001
APA StyleCurrent Oncology Editorial Office. (2009). Erratum. Current Oncology, 16(5), 120. https://doi.org/10.3390/curroncol16050001
